Ushbu ish iqtibos qilgan ishlar

61 ta ish

Ish: COVID-19: well-known drugs, new opportunities

1. La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19

   Martínez González, Marina

   Maqola202014 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.025583

2. A pneumonia outbreak associated with a new coronavirus of probable bat origin

   Peng Zhou, Xing‐Lou Yang, Xian-Guang Wang +26

   Maqola202012 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.210913

3. A Novel Coronavirus from Patients with Pneumonia in China, 2019

   Na Zhu, Dingyu Zhang, Wenling Wang +15

   Maqola202011 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.208170

4. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

   Dawei Wang, Bo Hu, Chang Hu +11

   Maqola202011 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.210914

5. Correspondence - Tranexamic acid for traumatic brain injury

   Sasieni, Peter D; id_orcid 0000-0003-1509-8744, Duffy, Stephen W, Cuzick, Jack

   Maqola200511 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.231706

6. COVID-19: consider cytokine storm syndromes and immunosuppression

   Puja Mehta, Daniel F. McAuley, Michael Brown +3

   Maqola20205 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.379742

7. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

   Manli Wang, Ruiyuan Cao, Leike Zhang +7

   Boshqa20204 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.278319

8. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study

   Jérôme R. Lechien, Carlos M. Chiesa‐Estomba, Daniele R. de Siati +30

   Maqola20204 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.507205

9. Emerging coronaviruses: Genome structure, replication, and pathogenesis

   Yu Chen, Qianyun Liu, Deyin Guo

   Sharh maqola20203 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.318504

10. Coronavirus infections and immune responses

    Geng Li, Yaohua Fan, Yanni Lai +9

    Sharh maqola20203 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.507179

11. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19

    Andrea Cortegiani, Giulia Ingoglia, Mariachiara Ippolito +2

    Sharh maqola20203 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.507190

12. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

    Martin J. Vincent, Éric Bergeron, Suzanne Benjannet +5

    Maqola20052 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.318500

13. RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

    Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola +15

    Maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.318507

14. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

    Shutoku Matsuyama, Naganori Nao, Kazuya Shirato +15

    Maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.368982

15. Vitamin D and the Immune System

    Cynthia Aranow

    Sharh maqola20112 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.507164

16. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells

    Markus Hoffmann, Hannah Kleine‐Weber, Nadine Krüger +3

    Preprint20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.507180

17. Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV

    Jared S. Morse, Tyler Lalonde, Shiqing Xu +1

    Maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.507185

18. Discovering drugs to treat coronavirus disease 2019 (COVID-19)

    Liying Dong, Shasha Hu, Jianjun Gao

    Maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.507192

19. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus

    Miguel Ángel Martı́nez

    Sharh maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.507193

20. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

    Philippe Colson, Jean‐Marc Rolain, Jean‐Christophe Lagier +2

    Boshqa20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.507194

21. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence

    Yuchen Cao, Qixin Deng, Shixue Dai

    Sharh maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.507201

22. Dapsone and doxycycline could be potential treatment modalities for COVID-19

    Ahmed Farouk, Samar Salman

    Boshqa20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.507210

23. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.507165

24. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.507166

25. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.507167